Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1651-1660 of 2905 for cancer

Edit search filters
  1. A Study Of Ramucirumab Plus Docetaxel In Patients With Urothelial Cancer

    Rochester, MN

  2. A Study Of ABBV-085, An Antibody Drug Conjugate, For Patients With Advanced Solid Cancer Tumors

    Scottsdale/Phoenix, AZ

  3. A Study To Evaluate CTX110 In Subjects With Relapsed Or Refractory B-Cell Malignancies

    Jacksonville, FL

  4. Study Comparing Daratumumab, Lenalidomide, And Dexamethasone With Lenalidomide And Dexamethasone In Participants With Previously Untreated Multiple Myeloma

    Jacksonville, FL, Rochester, MN

  5. A Study Of Acceptance And Commitment Therapy In Patients With Myeloproliferative Neoplasms

    Scottsdale/Phoenix, AZ

  6. Study Of HPN536 In Patients With Advanced Cancers Associated With Mesothelin Expression

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. A Phase I, Multi-Center, Open Label, Dose De-escalation And Expansion Study Of Gemcitabine And Cisplatin With AG120 Or Pemigatinib For Advanced Cholangiocarcinoma

    Scottsdale/Phoenix, AZ, Rochester, MN

  8. An Extension Study MRI/US Fusion Imaging And Biopsy In Combination With Nanoparticle Directed Focal Therapy For Ablation Of Prostate Tissue

    Rochester, MN

  9. A Study To Detect Minimally-Invasive Barrett's Esophagus And Barrett's Esophagus Related Dysplasia/Carcinoma

    Scottsdale/Phoenix, AZ, Austin, MN, Jacksonville, FL, Mankato, MN, Rochester, MN

  10. Pembrolizumab Alone Or With Idelalisib Or Ibrutinib In Treating Patients With Relapsed Or Refractory Chronic Lymphocytic Leukemia Or Other Low-Grade B-Cell Non-Hodgkin Lymphomas

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer